Worth Venture Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$4.98M |
| 2 |
Amgen
AMGN
|
+$2.4M |
| 3 |
Booking.com
BKNG
|
+$2.14M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$2.13M |
| 5 |
NNDM
Nano Dimension
NNDM
|
+$1.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$2.81M |
| 2 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$2.32M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.44M |
| 4 |
Calix
CALX
|
+$1.11M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.5% |
| 2 | Technology | 5.71% |
| 3 | Consumer Discretionary | 1.17% |
| 4 | Industrials | 1.07% |
| 5 | Energy | 0.53% |
Similar funds
Worth Venture Partners's Q1 2019 Portfolio in Review
As of Q1 2019, Worth Venture Partners held 129 positions worth $180M, up 36% from $132M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Worth Venture Partners withdrew a net $45.9M in Q1 2019, closing 31 positions and reducing 26 holdings. Its most notable exit was State Street SPDR Portfolio Short Term Corporate Bond ETF, an estimated $2.32M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 8.5% of assets, up from 3.7% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Worth Venture Partners opened a new position in Biogen worth $3.73M.
- Worth Venture Partners's largest Q1 2019 buy was Biogen: 15,800 shares worth $3.73M.
- Worth Venture Partners added most to BioMarin Pharmaceuticals in Q1 2019, an estimated $2.13M increase.
- Worth Venture Partners's biggest Q1 2019 reduction was Qualcomm, cutting an estimated $2.81M.
- Worth Venture Partners fully exited State Street SPDR Portfolio Short Term Corporate Bond ETF in Q1 2019, selling an estimated $2.32M.
- Worth Venture Partners's ten largest holdings make up 71% of its $180M portfolio in Q1 2019.
- Worth Venture Partners opened 37 new positions and closed 31 in Q1 2019.
- Worth Venture Partners's portfolio value rose 36% quarter-over-quarter to $180M.
Based on Worth Venture Partners's 13F filing for Q1 2019, filed 15 May 2019.